Analyst Target Price Look at Valeant Pharmaceuticals International, Inc. (NYSE:VRX), The Coca-Cola Co (NYSE:KO)

Analyst Target Price Look at Valeant Pharmaceuticals International, Inc. (NYSE:VRX), The Coca-Cola Co (NYSE:KO)

Research analysts covering Valeant Pharmaceuticals International, Inc. (NYSE:VRX) are projecting that the shares reach $42 within the next 12-18 months.  This is the consensus number derived from the 11 analyst reports taken into consideration. The most bullish, or aggressive analyst target pins the projected price at $81, while the most bearish, or conservative analyst sees the stock reaching $22.

Broker Rating Update on Valeant Pharmaceuticals International, Inc. (NYSE:VRX)

Zacks provides analysts with an Average Broker Rating (or ABR), basing it on sell-side recommendations. Shares of Valeant Pharmaceuticals International, Inc. (NYSE:VRX) currently have an ABR of 2.61. This is based on a simplified 1 to 5 scale where 1 represents a Strong Buy and 5 a Strong Sell.  Moving to earnings estimates, for this current fiscal period, Wall Street analysts have projected that the company will post $1.81 earnings per share. This is the current Zacks consensus EPS which was calculated at the time of writing. Analysts will likely revise their estimates leading in to the actual results date.  

taking a look at the most recent period, which closed on 2016-06-30, Valeant Pharmaceuticals International, Inc. reported EPS of $1.4 for a surprise factor of -11.95%, calculated by being $-0.19 away from analyst projections.

Investors will be marking their calendars for 2016-10-17, when the company is planning to release their quarterly results.

Research analysts covering The Coca-Cola Co (NYSE:KO) are projecting that the shares reach $47.181 within the next 12-18 months.  This is the consensus number derived from the 11 analyst reports taken into consideration. The most bullish, or aggressive analyst target pins the projected price at $52, while the most bearish, or conservative analyst sees the stock reaching $40.

Broker Rating Update on The Coca-Cola Co (NYSE:KO)

Zacks provides analysts with an Average Broker Rating (or ABR), basing it on sell-side recommendations. Shares of The Coca-Cola Co (NYSE:KO) currently have an ABR of 2.35. This is based on a simplified 1 to 5 scale where 1 represents a Strong Buy and 5 a Strong Sell.  Moving to earnings estimates, for this current fiscal period, Wall Street analysts have projected that the company will post $0.49 earnings per share. This is the current Zacks consensus EPS which was calculated at the time of writing. Analysts will likely revise their estimates leading in to the actual results date.  

taking a look at the most recent period, which closed on 2016-06-30, The Coca-Cola Co reported EPS of $0.6 for a surprise factor of 3.45%, calculated by being $0.02 away from analyst projections.

Investors will be marking their calendars for 2016-10-19, when the company is planning to release their quarterly results.

COMMENTS

WORDPRESS: 0